Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women
- PMID: 36319702
- DOI: 10.1007/s00403-022-02444-x
Immune-mediated diseases and subsequent risk of alopecia areata in a prospective study of US women
Abstract
Introduction: Alopecia areata (AA) is the most common form of immune-mediated hair loss. Studies have begun to establish the most frequent comorbid diseases of AA; however, results have been inconsistent with few prospective studies.
Methods: A total of 63,692 women in the Nurses' Health Study, 53-80 years, were prospectively followed from 2002 to 2014 to determine whether history of immune-mediated disease was associated with AA risk. Hazard ratios (HRs) and 95% confidence intervals (CIs) for AA in relation to immune-mediated conditions were computed using Cox proportional hazard models, adjusted for AA risk factors.
Results: 133 AA cases were identified during follow-up. Personal history of any immune-mediated disease was associated with increased AA risk (HR 1.72, 95% CI 1.24-2.37). History of systemic lupus erythematosus (HR 5.43, 95% CI 2.11-13.97), multiple sclerosis (HR 4.10, 95% CI 1.40-11.96), vitiligo (HR 3.13, 95% CI 1.08-9.10), psoriasis (HR 2.01, 95% CI 1.00-4.03), hypothyroidism (HR 1.88, 95% CI 1.30-2.71), and rheumatoid arthritis (HR 1.66, 95% CI 1.09-2.52) were associated with increased AA risk. History of inflammatory bowel disease or Graves' disease/hyperthyroidism was not significantly associated with AA risk.
Conclusions: In this prospective study, personal history of immune-mediated diseases either individually or overall was associated with increased AA risk.
Keywords: Alopecia areata; Autoimmune skin diseases; Comorbidities; Epidemiology; Immune-mediated diseases; Nurses’ Health Study.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Similar articles
-
Autoimmune, Inflammatory, Atopic, Thyroid, and Psychiatric Outcomes of Offspring Born to Mothers With Alopecia Areata.JAMA Dermatol. 2023 Jul 1;159(7):711-719. doi: 10.1001/jamadermatol.2023.1261. JAMA Dermatol. 2023. PMID: 37223925 Free PMC article.
-
Incident alopecia areata and vitiligo in adult women with atopic dermatitis: Nurses' Health Study 2.Allergy. 2017 May;72(5):831-834. doi: 10.1111/all.13128. Epub 2017 Feb 6. Allergy. 2017. PMID: 28101886 Free PMC article.
-
Estimated serum vitamin D status, vitamin D intake, and risk of incident alopecia areata among US women.Arch Dermatol Res. 2016 Nov;308(9):671-676. doi: 10.1007/s00403-016-1687-y. Epub 2016 Sep 23. Arch Dermatol Res. 2016. PMID: 27664090
-
Familial patterns of alopecia areata: A systematic review and meta-analysis.J Autoimmun. 2025 Feb;151:103378. doi: 10.1016/j.jaut.2025.103378. Epub 2025 Feb 6. J Autoimmun. 2025. PMID: 39919410
-
Increased Incidence of Thyroid Disease in Patients with Alopecia Areata: A Systematic Review and Meta-Analysis.Dermatology. 2020;236(3):251-254. doi: 10.1159/000502025. Epub 2019 Oct 16. Dermatology. 2020. PMID: 31618741
Cited by
-
Thyroid Dysfunction and Alopecia Areata: A Genetic Prediction Causality Analysis Study.Skin Res Technol. 2024 Oct;30(10):e70063. doi: 10.1111/srt.70063. Skin Res Technol. 2024. PMID: 39331482 Free PMC article.
-
Mendelian randomization study highlights hypothyroidism as a causal determinant of alopecia areata.Front Endocrinol (Lausanne). 2024 Jan 16;14:1309620. doi: 10.3389/fendo.2023.1309620. eCollection 2023. Front Endocrinol (Lausanne). 2024. PMID: 38292771 Free PMC article.
-
The genetic link between thyroid dysfunction and alopecia areata: a bidirectional two-sample Mendelian randomization study.Front Endocrinol (Lausanne). 2024 Aug 14;15:1440941. doi: 10.3389/fendo.2024.1440941. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39205687 Free PMC article.
-
Overview of alopecia areata for managed care and payer stakeholders in the United States.J Manag Care Spec Pharm. 2023 Jul;29(7):848-856. doi: 10.18553/jmcp.2023.22371. Epub 2023 May 23. J Manag Care Spec Pharm. 2023. PMID: 37219075 Free PMC article.
-
Prevalence and Association of Autoimmune Comorbidities Among Adults with Vitiligo: A Systematic Literature Review and Meta-analysis of USA-Based Studies.Dermatol Ther (Heidelb). 2025 Aug 19. doi: 10.1007/s13555-025-01506-y. Online ahead of print. Dermatol Ther (Heidelb). 2025. PMID: 40828230 Review.
References
References:
MeSH terms
Supplementary concepts
Grants and funding
LinkOut - more resources
Full Text Sources